Skip to main content
OpenTrials

Clinical trial condition

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities

Explore clinical trials studying Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities. Study availability and eligibility vary by location and protocol.

113 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities trial results

Completed

Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia

NCT00352365

Conditions
Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7), +31 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Shasta Regional Medical Center Redding, California, United States
  • Sutter Roseville Medical Center Roseville, California, United States
  • Sutter General Hospital Sacramento, California, United States
View all 54 locations
View Trial Details
Completed

Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

NCT00860574

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +50 more
Locations
  • University of Colorado Denver, Colorado, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

NCT00489203

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, +207 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Fred Hutchinson Cancer Research Center Seattle, Washington, United States
View Trial Details

Related conditions